US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 55.8400
- -2.5000-4.29%
Close Nov 27 16:00 ET
- 49.4000
- -6.4400-11.53%
Post 20:01 ET
2.41BMarket Cap-20014P/E (TTM)
58.8800High55.1501Low543.04KVolume58.5100Open58.3400Pre Close30.42MTurnover1.95%Turnover RatioLossP/E (Static)43.12MShares60.920052wk High9.10P/B1.56BFloat Cap27.270052wk Low--Dividend TTM27.90MShs Float742.5000Historical High--Div YieldTTM6.39%Amplitude0.8500Historical Low56.0150Avg Price1Lot Size
Soleno Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 747.51%79.34M | 179.55%23.23M | 182.42%23.07M | 54.01%38.67M | 106.52%12.83M | 53.38%9.36M | 34.84%8.31M | 23.21%8.17M | -22.16%25.11M | -1.86%6.21M |
| Selling and administrative expenses | 1,382.73%49.2M | 243.61%10.89M | 196.85%8.47M | 36.95%13.48M | 72.36%4.14M | 42.28%3.32M | 28.46%3.17M | 7.98%2.85M | -8.90%9.84M | -7.47%2.4M |
| -General and administrative expense | 1,382.73%49.2M | 243.61%10.89M | 196.85%8.47M | 36.95%13.48M | 72.36%4.14M | 42.28%3.32M | 28.46%3.17M | 7.98%2.85M | -8.90%9.84M | -7.47%2.4M |
| Research and development costs | 398.73%30.14M | 140.07%12.34M | 174.68%14.6M | 65.01%25.19M | 128.06%8.69M | 60.25%6.04M | 39.10%5.14M | 33.30%5.32M | -28.84%15.27M | 2.04%3.81M |
| Operating profit | -747.51%-79.34M | -179.55%-23.23M | -182.42%-23.07M | -54.01%-38.67M | -106.52%-12.83M | -53.38%-9.36M | -34.84%-8.31M | -23.21%-8.17M | 22.16%-25.11M | 1.86%-6.21M |
| Net non-operating interest income expense | 1,966.67%3.6M | 1,950.34%3.01M | 1,738.05%2.08M | 759.33%2.58M | 1,615.20%2.14M | 72.28%174K | 182.69%147K | 413.64%113K | 172.73%300K | 267.65%125K |
| Non-operating interest income | 1,966.67%3.6M | 1,950.34%3.01M | 1,738.05%2.08M | 759.33%2.58M | 1,615.20%2.14M | 72.28%174K | 182.69%147K | 413.64%113K | 172.73%300K | 267.65%125K |
| Other net income (expense) | 47.61%-877K | -424.68%-1.64M | -34.11%-401K | -490.30%-2.9M | -201.66%-611K | -1,187.69%-1.67M | 49.19%-312K | -133.79%-299K | -40.11%742K | -82.67%601K |
| Gain on sale of security | ---- | ---- | ---- | -706.67%-182K | 47,100.00%470K | -32,750.00%-653K | -50.00%1K | ---- | -94.09%30K | -100.72%-1K |
| Special income (charges) | 14.10%-877K | -423.00%-1.64M | -34.11%-401K | -481.18%-2.71M | -279.57%-1.08M | -673.48%-1.02M | 49.19%-313K | -134.85%-299K | -2.60%712K | -81.92%602K |
| -Less：Restructuring and merger&acquisition | -14.10%877K | 423.00%1.64M | 34.11%401K | 481.18%2.71M | 279.57%1.08M | 673.48%1.02M | -49.19%313K | 134.85%299K | 2.60%-712K | 81.92%-602K |
| Income before tax | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Income tax | ||||||||||
| Net income | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Net income continuous Operations | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M | 22.14%-24.07M | -93.99%-5.49M |
| Basic earnings per share | -92.63%-1.83 | 29.63%-0.57 | 32.95%-0.59 | 17.77%-2.36 | 38.52%-0.3566 | -46.15%-0.95 | -12.50%-0.81 | 17.76%-0.88 | 50.60%-2.87 | -9.43%-0.58 |
| Diluted earnings per share | -92.63%-1.83 | 29.63%-0.57 | 32.95%-0.59 | 17.77%-2.36 | 38.52%-0.3566 | -46.15%-0.95 | -12.50%-0.81 | 17.76%-0.88 | 50.60%-2.87 | -9.43%-0.58 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data